Page 25 - GTM-3-2
P. 25

Global Translational Medicine                                         Impact of flavonoids on vascular health



            site Ser1177 and dephosphorylation at the inhibition site   Flavonoids’ potent-free radical scavenging activity
            Thr495.  The latter mechanism involves a prooxidant   safeguards  NO from  ROS-mediated inactivation,
                  61
            effect, as indicated by its prevention with permeant analogs   preventing peroxynitrite and nitrotyrosine formation
                                                                                                  72
                  20
            of SOD.  However, the impact of isolated flavonols such   and contributing to their  in vivo benefits.  In addition,
            as quercetin on eNOS expression and endothelial NO   they impede LDL oxidation, a key step in atherosclerotic
            production in in vitro studies remains contentious, with   plaque formation.  Their chelation of pro-oxidant metals
                                                                             47
            conflicting results based on oxidative stress conditions.    further mitigates Fenton reactions and the generation
                                                         62
                                                                                                     65
            Quercetin may scavenge NO under  no oxidative stress,   of  highly  DNA-damaging  hydroxyl  radicals.   Beyond
            leading to its auto-oxidation and generation of O ,   ROS scavenging, flavonoids enhance NO availability by
                                                         2-
            ultimately inactivating NO.  It could also reduce eNOS   inhibiting ROS-generating enzymes like 5-lipoxygenase,
                                  63
            expression in tumor necrosis factor-alpha (TNF-α)-  COX,  xanthine  oxidase,  and NADPH oxidase, while
            stimulated endothelial cells  and normalize upregulated   upregulating antioxidant enzymes such as SOD,
                                  64
                                                                                  73
            eNOS in aortas from spontaneously hypertensive     CAT, and peroxidase.  Moreover, they may prevent
            rats (SHR).  In aortic rings from normotensive and   tetrahydrobiopterin oxidation and eNOS uncoupling,
                     33
                                                                                                      59
            hypertensive animals, quercetin therapy over an extended   preserving eNOS function as an NO producer.  Recent
            period of time may not increase endothelium-dependent   evidence suggests that flavonoids can improve endothelial
            relaxation to  insulin, indicating  a direct inhibitory   function under hypertensive and hyperglycemic conditions
            effect on PI3-K/Akt-dependent eNOS phosphorylation.   by attenuating ER stress through ROS reduction, likely due
            However, due to its antioxidant qualities, quercetin may   to their antioxidant properties. However, further research
            improve impaired endothelium-dependent vasodilation   is needed to solidify the protective effects against ER stress-
            under conditions of increased oxidative stress, suggesting   associated oxidative stress and vascular dysfunction. 36,56
            that NO production is not directly affected but rather that   Flavonoids further contribute to endothelial protection
            NO-dependent vasodilation is increased due to reduced   by downregulating vasoconstrictor mediators, including
            O -driven NO inactivation. 33,65                   Ang II, ET-1, and PGIs. Their interference with Ang
             2
              Moreover, flavonoids possess the ability to increase   II synthesis involves modulating ACE activity or its
            the production of NO in endothelial cells by suppressing   signaling pathways. 26,46  Quercetin and epicatechin, among
            the  expression  of caveolin-1  (Cav-1).  Cav-1  functions   others, suppress ET-1 production through Akt-mediated
            as a significant negative regulator of eNOS activity in   transcriptional regulation, demonstrated in both in vitro
            endothelial cells. This effect occurs through the activation   and in vivo studies. 27,55
            of extracellular-signal-regulated kinases 1/2 (ERK1/2)   Molecular targets implicated in the vasculoprotective
            and the inhibition of p38 mitogen-activated protein   effects of flavonoids include arginase-2 (ARG2), nuclear
            kinase (p38MAPK) signaling pathways. 66,67  In addition,   factor erythroid 2-related factor 2 (Nrf2), and sirtuin
            flavonoids have been shown to inhibit various isoforms   1 (SIRT-1). By reducing arginase-2 activity, flavonoids
            of  phosphodiesterases,  which  play  a  critical  role  in   prevent L-arginine competition with eNOS, subsequently
            NO-mediated  relaxation  and  endothelium-dependent   inhibiting NO formation.  Activation of Nrf2 by quercetin
                                                                                   74
            relaxation. It is worth noting that certain flavonoids, such   and EGCG upregulates antioxidant enzymes via the Nrf2/
            as kaempferol, can enhance the relaxant response to the   ARE pathway, enhancing cellular defense against oxidative
            soluble guanylyl cyclase activator sodium nitroprusside. 69  stress.  SIRT-1 directly interacts with eNOS, deacetylating
                                                                    75
              Flavonoid-mediated inhibition of endothelium-derived   it at Lys496 and Lys506 to promote vasodilation and
                                                                                  76
            vasoconstrictors, particularly PGIs, has been proposed as   enhance eNOS activity.  Given that downregulation or
            a mechanism for preventing endothelial dysfunction, as   pharmacological inhibition of SIRT-1 is closely linked
                                                                                      77
            evidenced by quercetin’s action.  Conversely, flavonoids   to endothelial dysfunction,  recent evidence suggests
                                      70
            can indirectly induce vasodilation by enhancing NO   that  quercetin  may  act  as a  SIRT-1  activator,  potentially
                                                                                                  78
            bioavailability through several pathways, which include   ameliorating impaired endothelial function.
            scavenging  ROS,  reducing  endogenous  eNOS  inhibitors   The vasculature harbors inherent anti-inflammatory
            such  as  asymmetric  dimethylarginine,  blocking  and anti-proliferative properties that augment the
            vasoconstrictor  release (endothelin-1 [ET-1] and   potential antihypertensive and antiatherosclerotic effects
            angiotensin II [Ang II]), and inhibiting enzymes involved   of flavonoids. In the context of vascular pathology,
            in NO inactivation (nicotinamide adenine dinucleotide   inflammation stands as a pivotal element, characterized by
            phosphate [NADPH] oxidase, acetylcholinesterase, and   the excessive production of proinflammatory agents and
            angiotensin-converting enzyme [ACE]). 71           adhesion molecules, frequently orchestrated by nuclear


            Volume 3 Issue 2 (2024)                         5                               doi: 10.36922/gtm.2458
   20   21   22   23   24   25   26   27   28   29   30